931 related articles for article (PubMed ID: 15767352)
1. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
4. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
5. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
9. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
10. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
[TBL] [Abstract][Full Text] [Related]
12. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors and breast cancer risk in Chinese women.
Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
[TBL] [Abstract][Full Text] [Related]
16. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
17. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
Vatten LJ; Holly JM; Gunnell D; Tretli S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
[TBL] [Abstract][Full Text] [Related]
18. Body shape throughout life and correlations with IGFs and GH.
Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
